仁東控股(002647.SZ)連續13日跌停 自最高位跌去76.38%
格隆匯12月11日丨仁東控股(002647.SZ)今日繼續上演一字跌停,報15.29元,跌停封單超16萬手,股價創2019年11月以來新低,最新市值86億元。該股已連續13日跌停(連續16日下跌),股價較11月20日創出的歷史最高價64.72元已跌去76.38%,市值蒸發276億元。該股今年一度從16.74元上漲至64.72元,年內一度累漲286%。繼媒體曝出仁東控股莊家已被司法控制、深交所宣佈仁東控股融資買入被暫停後,昨晚關於該股又有新爆料,有接近上海執法部門的人士稱,一名從事場外配資和虛擬盤交易的資本大佬李躍宗已被浦東警方控制,而李躍宗很可能與仁東控股坐莊高度相關。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.